Abstract
Using mouse models of osteoarthritis (OA), a new study finds that osteoclasts secrete exosomes that deliver miRNAs to chondrocytes, leading to an increase in metalloproteinase activity in cartilage. A bone-specific inhibitor of exosome production can halt this process, hinting at a new therapeutic strategy for patients with OA.
Original language | English |
---|---|
Article number | 1 |
Pages (from-to) | 332 |
Number of pages | 334 |
Journal | Nature Aging |
Publication status | Published - 15 Apr 2021 |